{{Rsnum
|rsid=366676
|Chromosome=6
|position=88008048
|Orientation=minus
|GMAF=0.4587
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 16.8 | 56.6 | 26.5
| HCB | 65.0 | 32.1 | 2.9
| JPT | 55.8 | 38.9 | 5.3
| YRI | 11.0 | 47.6 | 41.4
| ASW | 14.0 | 45.6 | 40.4
| CHB | 65.0 | 32.1 | 2.9
| CHD | 56.0 | 39.4 | 4.6
| GIH | 24.8 | 50.5 | 24.8
| LWK | 16.4 | 44.5 | 39.1
| MEX | 31.0 | 63.8 | 5.2
| MKK | 16.1 | 47.7 | 36.1
| TSI | 14.7 | 41.2 | 44.1
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs366676
|PubMedID=17903301
|Condition=Echocardiographic traits
|Gene=SPACA1
|Risk Allele=
|pValue=2.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs366676
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903301; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study (Initial Sample Size: 1,238 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Echocardiographic traits.
|Drugs=
|Drug Classes=
|Diseases=Cardiovascular Diseases
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356468
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs366676
|overall_frequency_n=57
|overall_frequency_d=128
|overall_frequency=0.445312
|n_genomes=37
|n_genomes_annotated=0
|n_haplomes=48
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}